Literature DB >> 15142475

Psychotic symptoms in patients with medical disorders.

Ashwin A Patkar1, Rajnish Mago, Prakash S Masand.   

Abstract

Psychotic symptoms frequently occur in patients with comorbid medical disorders and present a diagnostic and treatment challenge. They may be a part of an independent psychiatric illness associated with the underlying medical condition or induced by substance use or medications. The presence of psychotic symptoms can contribute to misdiagnosis or complicate the management of the comorbid medical illness. Psychiatrists must be familiar with the assessment and management of psychotic disorders in patients with comorbid medical disorders. Medications that may be used to treat psychosis include antipsychotic agents, benzodiazepines, or possibly certain anticonvulsants. Selecting the appropriate medication requires knowledge of the pharmacokinetics of different agents and their side effect profile. Understanding the neuropsychiatric effects of medications and drug-drug interactions may help in preventing psychotic symptoms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15142475     DOI: 10.1007/s11920-004-0067-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  69 in total

1.  Dysrhythmia associated with clozapine.

Authors:  S Varma; K Achan
Journal:  Aust N Z J Psychiatry       Date:  1999-02       Impact factor: 5.744

2.  Atypical antipsychotic agents in the treatment of Schizophrenia and other psychiatric disorders. Part II: Special considerations.

Authors: 
Journal:  J Clin Psychiatry       Date:  1998-06       Impact factor: 4.384

3.  The treatment of unrelated disorders in patients with chronic medical diseases.

Authors:  D A Redelmeier; S H Tan; G L Booth
Journal:  N Engl J Med       Date:  1998-05-21       Impact factor: 91.245

4.  Concurrent medical illness in the schizophrenic patient. Epidemiology, diagnosis, and management.

Authors:  L E Adler; J M Griffith
Journal:  Schizophr Res       Date:  1991 Mar-Apr       Impact factor: 4.939

5.  Clozapine-related seizures.

Authors:  O Devinsky; G Honigfeld; J Patin
Journal:  Neurology       Date:  1991-03       Impact factor: 9.910

6.  Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.

Authors:  J S Street; W S Clark; K S Gannon; J L Cummings; F P Bymaster; R N Tamura; S J Mitan; D L Kadam; T M Sanger; P D Feldman; G D Tollefson; A Breier
Journal:  Arch Gen Psychiatry       Date:  2000-10

7.  Exacerbation of psychosis by misinterpretation of physical symptoms.

Authors:  Roy R Reeves; Rafael A Torres
Journal:  South Med J       Date:  2003-07       Impact factor: 0.954

8.  Clinical effects of recent cocaine use on patients with acute schizophrenia.

Authors:  M R Serper; M Alpert; N A Richardson; S Dickson; M H Allen; A Werner
Journal:  Am J Psychiatry       Date:  1995-10       Impact factor: 18.112

9.  Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.

Authors:  Hubert H Fernandez; Martha E Trieschmann; Monica A Burke; Joseph H Friedman
Journal:  J Clin Psychiatry       Date:  2002-06       Impact factor: 4.384

Review 10.  Ziprasidone metabolism, aldehyde oxidase, and clinical implications.

Authors:  Christine Beedham; Jeffrey J Miceli; R Scott Obach
Journal:  J Clin Psychopharmacol       Date:  2003-06       Impact factor: 3.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.